Robinhood Markets, Inc. vs GeneDx Holdings Corp — how do they compare? Robinhood Markets, Inc. trades at $106.92 (market cap $89.13B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Robinhood Markets, Inc. is far larger — about 49.5× GeneDx Holdings Corp's market cap, and Robinhood Markets, Inc. is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| HOOD | WGS | |
|---|---|---|
Market Cap | $89.13B | $1.80B |
Sector | Technology | Technology |
52-Week High | $152.46 | $167.51 |
52-Week Low | $65.16 | $34.51 |
Enterprise Value | $90.33B | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →